DVAX · As filed with the SEC
Dynavax Technologies income statement, by quarter
The statement as Dynavax Technologies presents it in its 10-Q and 10-K: its own lines, labels and order. Tables over time lines up standardized figures across every filing.
Condensed Consolidated Statements of Operations · USD thousands, except per-share amounts; shares in thousands
| USD thousands, except per-share amounts; shares in thousands | Q3 2025 3 months ended Sep 30, 2025 | Q2 2025 3 months ended Jun 30, 2025 | Q1 2025 3 months ended Mar 31, 2025 | Q4 2024† 3 months ended Dec 31, 2024 |
|---|---|---|---|---|
| Revenues: | ||||
| Total revenues | 94,876 | 95,442 | 68,164 | 72,032† |
| Product revenue, net | 89,954 | 91,872 | 64,959 | 71,053† |
| Other revenue | 4,922 | 3,570 | 3,205 | 979† |
| Operating expenses: | ||||
| Cost of sales - product | 14,403 | 14,035 | 13,769 | 13,410† |
| Research and development | 19,116 | 16,619 | 19,377 | 18,669† |
| Selling, general and administrative | 40,086 | 50,359 | 47,678 | 41,585† |
| Gain on sale of assets (Note 8) | — | — | — | 0† |
| Bad debt expense (Note 9) | — | — | — | 0† |
| Bad debt expense | 0 | 0 | 10,970 | — |
| Total operating expenses | 73,605 | 81,013 | 91,794 | 73,664† |
| Income (loss) from operations | 21,271 | 14,429 | (23,630) | (1,632)† |
| Other income (expense): | ||||
| Interest income | 6,593 | 6,798 | 7,739 | 8,414† |
| Interest expense | (1,643) | (1,641) | (1,692) | (1,704)† |
| Sublease income | 2,225 | 2,226 | 2,226 | — |
| Loss on debt extinguishment | 0 | 0 | (82,095) | — |
| Other loss | (27) | (596) | (423) | 345† |
| Net income (loss) before income taxes | 28,419 | 21,216 | (97,875) | 7,629† |
| Provision for income taxes | (1,492) | (2,495) | 1,776 | (579)† |
| Net income (loss) | 26,927 | 18,721 | (96,099) | 7,050† |
| Net income (loss) per share: | ||||
| Basic (in USD per share) | 0.23 | 0.16 | (0.77) | — |
| Diluted (in USD per share) | 0.21 | 0.14 | (0.77) | — |
| Weighted-average shares used in computing net income (loss) per share: | ||||
| Basic (in shares) | 117,307 | 119,317 | 124,871 | — |
| Diluted (in shares) | 136,468 | 138,356 | 124,871 | — |
† Derived: worked out from the filings, not stated in them. A fourth quarter is the 10-K year less the nine months in the third-quarter 10-Q; a quarter of cash flows is year to date less the prior year to date.
As filed on EDGAR · Not affiliated with the U.S. SEC · Not investment advice. Each column links to its filing.